TiumBio inks licensing deal with China's Hansoh for endometriosis drug

TiumBio inks licensing deal with China's Hansoh for endometriosis drug

South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...

TiumBio acquires stake in SK Plasma to beef up R&D for rare diseases

TiumBio acquires stake in SK Plasma to beef up R&D for rare diseases

South Korea-based biopharmaceutical company TiumBio is set to acquire 30 billion won ($26 million) worth of shares in SK Plasma, a blood product com...

S.Korea’s US exports tumble in August as tariff shocks set in Tesla fuels 55% surge in Korea’s online car sales, lifting e-commerce Car sharing: appealing option among Korean MZers as young drivers shun ownership Shinhan Financial bets on stablecoins, AI in digital overhaul   S.Korean firms rush to retire treasury shares before law reform
banner